Edwards SAPIEN 3 TAVI — approved for all severe aortic stenosis (sAS) patients irrespective of surgical risk
A proven story of continuous innovation and
The first-in-human Edwards-Cribier valve was implanted by Prof. Alain Cribier in 2002 showing the feasibility of transcatheter aortic valve implantation (TAVI) concept.1
As Edwards received the CE Mark for SAPIEN valve in 2007,2 the company has set the stage to continue innovating in TAVI, bringing new technologies with improved clinical outcomes.3-6